Fan, Birao, and Mingyue Wang. “Ruxolitinib, a JAK1/2 Inhibitor As Treatment for Paraneoplastic Pemphigus: A Case Report”. Acta Dermato-Venereologica 102 (June 9, 2022): adv00732. Accessed April 16, 2024. https://medicaljournalssweden.se/actadv/article/view/1378.